Bupropion HCl Sandoz retard 150 mg, tabletten met gereguleerde afgifte
This medicine has been approved for use for the indication as stated here.
Availability: Uitsluitend recept
About this medicine
| Active substance: |
-
BUPROPIONHYDROCHLORIDE
150 mg/stuk
SAMENSTELLING overeenkomend met
BUPROPION
130.2 mg/stuk
|
| ATC: |
N06AX12 - Bupropion
|
| Excipients: |
-
AMMONIA (E 527)
-
COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1)
-
ETHYLCELLULOSE (E 462)
-
HYPROLOSE (E 463)
-
HYPROMELLOSE (E 464)
-
IJZEROXIDE ZWART (E 172)
-
MACROGOL 1500
-
MACROGOL 400
-
MACROGOL 8000
-
NATRIUMSTEARYLFUMARAAT
-
POVIDON K 90 (E 1201)
-
PROPYLEENGLYCOL (E 1520)
-
SCHELLAK GLAZE, GEDEELTELIJK VERESTERD
-
SILICIUMDIOXIDE (E 551)
-
TRIETHYLCITRAAT (E 1505)
-
ZOUTZUUR (E 507)
|
| Pharmaceutical form: |
Tablet met gereguleerde afgifte
|
| Route of Administration: |
Oraal gebruik
|
Patient information
You can find an extensive description of the efficacy and possible adverse events of this medicine in the patient information leaflet and summary of the product characteristics.
Patient information
Do you need more information on sickness and health? Take a look at 
Thuisarts.nl.
| Marketing authorisation number: |
RVG 114395 |
| Procedure number: |
NL/H/3042/001 |
| Authorisation date: |
16 April 2015 |
| Marketing authorisation holder: |
Sandoz B.V.
Hospitaaldreef 29
1315 RC ALMERE
|
